Can-Fite BioPharma Ltd. Selling, General and Administrative Expense
Can-Fite BioPharma Ltd. (CANF) reported Selling, General and Administrative Expense of $263.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-03-30
| Period end | Selling, General and Administrative Expense 12 month |
|---|---|
| 2022-12-31 | $263.00K 20-F · filed 2023-03-30 |
| 2021-12-31 | $466.00K 20-F · filed 2023-03-30 |
| 2020-12-31 | $317.00K 20-F · filed 2023-03-30 |